Detalles de la búsqueda
1.
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer.
Future Oncol
; 20(14): 891-901, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38189180
2.
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
N Engl J Med
; 382(23): 2187-2196, 2020 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469183
3.
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT).
J Urol
; 210(2): 299-311, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37126069
4.
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
J Urol
; 207(1): 61-69, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433303
5.
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance.
Prostate
; 81(1): 41-49, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33095939
6.
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines.
Prostate
; 80(6): 527-544, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32130741
7.
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
J Urol
; 210(3): 411-412, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37350185
8.
Reply by Authors.
J Urol
; 210(2): 310-311, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37416959
9.
Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancer.
BJU Int
; 119(2): 239-244, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26991743
10.
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
JAMA Oncol
; 10(5): 594-602, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451492
11.
Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases.
Target Oncol
; 18(1): 95-103, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36472728
12.
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
Adv Ther
; 40(11): 4919-4927, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37713020
13.
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
Cancers (Basel)
; 15(19)2023 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835548
14.
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer.
Clin Genitourin Cancer
; 21(3): 383-392.e2, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062659
15.
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
Eur Urol Oncol
; 2023 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38143206
16.
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.
Urol Oncol
; 41(11): 454.e9-454.e16, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734979
17.
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent.
Clin Cancer Res
; 28(13): 2789-2795, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416959
18.
The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial.
Eur Urol
; 78(2): 184-192, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273183
19.
Development and evaluation of the MiCheck test for aggressive prostate cancer.
Urol Oncol
; 38(8): 683.e11-683.e18, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32305266
20.
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial.
Urol Oncol
; 38(8): 683.e1-683.e10, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360170